Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
This partnership signifies a monumental step in regenerative medicine, notably in the sectors of active soft tissue repair,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Sep 23
This partnership signifies a monumental step in regenerative medicine, notably in the sectors of active soft tissue repair,…
12 Sep 23
Pfizer and BioNTech’s updated Covid-19 vaccine, Comirnaty 2023-2024, and Moderna’s Spikevax were indicated for people aged 12 years…
12 Sep 23
The CHRYSALIS-2 study cohort evaluated the safety and tolerability of the combination of Rybrevant with Lazertinib plus platinum-based…
12 Sep 23
SB17, a proposed biosimilar to Stelara (Ustekinumab), is Samsung Bioepis’ fourth candidate in the immunology pipeline, after SB4…
12 Sep 23
The FDA approval was supported by findings from the two-part, Phase 3 GENESIS trial in which the combination…
12 Sep 23
The partnership aims to pioneer innovative and transformative therapies for cancer patients facing substantial unmet medical needs
12 Sep 23
Vibegron Met Both Co-Primary Endpoints Demonstrating Statistically Significant Reductions in Daily Micturition and Urgency Episodes, Compared to Placebo…
12 Sep 23
Company Secures Significant Food and Beverage Industry Seal, Showcasing Dedication to Wholesome Ingredients
12 Sep 23
This transaction provides the Genentech and Roche R&D units with these three components of Herophilus’ discovery platform
11 Sep 23
Alexion will obtain access to the US-based biotechnology company’s CONVERGE platform to identify novel disease targets, in exchange…